Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Inflammasome and IL-1beta-mediated disorders Hoffman HM; Wanderer AACurr Allergy Asthma Rep 2010[Jul]; 10 (4): 229-35The NLRP3 inflammasome is an intracellular complex that regulates the release of proinflammatory cytokines such as interleukin-1beta in response to exogenous pathogens and endogenous danger signals. Evidence from studies involving human genetics, human ex vivo mononuclear cell responses, and in vivo and in vitro murine models confirms the importance of the inflammasome and interleukin-1beta in the pathogenesis of several inherited and complex diseases. The availability of several effective interleukin-1beta targeted therapies has allowed for successful proof-of-concept studies in several of these disorders. However, many other diseases are likely to be mediated by the inflammasome and interleukin-1beta, providing additional targets in the future.|Animals[MESH]|Asbestosis/drug therapy[MESH]|Carrier Proteins/*immunology[MESH]|Cryopyrin-Associated Periodic Syndromes/immunology[MESH]|Diabetes Mellitus, Type 2/drug therapy/immunology[MESH]|Gout/drug therapy/immunology[MESH]|Humans[MESH]|Inflammation/drug therapy/*immunology[MESH]|Interleukin-1beta/*antagonists & inhibitors/*immunology[MESH]|Lung Diseases/drug therapy[MESH]|Mice[MESH]|NLR Family, Pyrin Domain-Containing 3 Protein[MESH]|Silicosis/drug therapy[MESH] |
